Blood cancer drugs

These companies develop or sell drugs and cell therapies that treat leukemia, lymphoma, myeloma and other blood cancers.
+2.8%
over 1 month · S&P 500 −2.3%

Key indicators

Health
49 / 100
Fragile
Solid
Price
P/E 27
Cheap
Expensive
Up over 1 year
11 of 20
Volatility
71%
Calm
Choppy
Health and price: against the other tags.